Characterization and pre-clinical assessment of a proposed biosimilar to its originator Omalizumab-Reference-Cited by-同舟云学术

Characterization and pre-clinical assessment of a proposed biosimilar to its originator Omalizumab

Published:2022-11 Issue: Volume:178 Page:106292
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Wang Yanchao,Zheng Chen,Zhuang Chao,Fu Qiang,Zhang Baohong,Bian Yanling,Qi Nianmin,Zhu Jianwei

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference31 articles.

1. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects;Arm;Clin. Exp. Allergy,2014

2. Modelling asthma in macaques: longitudinal changes in cellular and molecular markers;Ayanoglu;Eur. Respir. J.,2011

3. Experiences with monoclonal antibody therapy for allergic asthma;Boushey;J. Allergy Clin. Immunol.,2001

4. Establishment of human IgE system in severe combined immunodeficient mice with peripheral blood mononuclear cells from asthmatic children;Chiang;J. Allergy Clin. Immunol.,1995

5. A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma;D'Amato;Ther. Clin. Risk Manag.,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly purified charge variants of a proposed biosimilar to Omalizumab: impact on in vitro potency and stability under thermal stress;Bioprocess and Biosystems Engineering;2023-12-29

2. Basic Regulatory Science Behind Drug Substance and Drug Product Specifications of Monoclonal Antibodies and Other Protein Therapeutics;Journal of Pharmaceutical Analysis;2023-12

3. Clinical inertia in asthma;npj Primary Care Respiratory Medicine;2023-10-14